Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Cambridge Laboratories

Cambridge Laboratories is a fast growing, dynamic and entrepreneurial pharmaceutical company with extensive product development and commercialisation expertise. Our focus is on specialist pharmaceuticals with core products in Oncology and diseases of the central nervous system (CNS).
We have a proven track record in the development, global registration, marketing, sales and distribution of both innovative and well established pharmaceutical products. This, combined with our strong product portfolio and our ability to forge lasting relationships with global partners, has helped us generate substantial sales growth over the past 10 years.We are proud of our independence and entrepreneurial culture. Equally, our strong balance sheet and freedom from debt give us a solid foundation from which we continue to enhance our growth.Our focus is very firmly on the future and the opportunity to augment further targeted product acquisitions with our own internal development pipeline, bringing to market products that will help us fulfil previously unmet patient needs.


Contact Details:
The Sweepstakes Ballsbridge
Dublin 4
Ireland
Tel:353 1 668 7895
Fax:353 1 631 9452
Email:marketing@camb-labs.com
WWW:

www.camb-labs.com/




Recent Publications by Cambridge Laboratories:

Quinazolin-4-piperidin-4-methyl sulfamide PC-1 inhibitors: alleviating hERG interactions through structure based design.
PC-1 (NPP-1) inhibitors may be useful as therapeutics for the treatment of...
22nd August, 2009
Pfizer Global Research and Development, Cambridge Laboratories, Cambridge, Bioorg Med Chem Lett. 2009 Jun 15;19(12):3339-43. Epub 2009 Apr 9.
DOI Direct Link
Identification and SAR around N-{2-[4-(2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-[1,4]diazepan-1-yl]-ethy l}-2-phenoxy-nicotinamide, a selective alpha2C adrenergic receptor antagonist.
The discovery of the CNS-penetrant and selective alpha(2C) adrenergic...
25th April, 2009
Pfizer Global Research and Development, Cambridge Laboratories, Cambridge, Bioorg Med Chem Lett. 2008 Oct 15;18(20):5689-93. Epub 2008 Aug 22.
DOI Direct Link
High yield expression of non-phosphorylated protein tyrosine kinases in insect cells.
The key role of kinases in signal transduction and cell growth regulation...
22nd January, 2009
Research Technology Center, Pfizer Cambridge Laboratories, 620 Memorial Protein Expr Purif. 2008 Oct;61(2):204-11. Epub 2008 Jun 5.
DOI Direct Link

Press Releases on Cambridge Laboratories:

BioPortfolio Logo
S&R Communications Group Partners With Ovation Pharmaceuticals to Launch Xenazine* (tetrabenazine) 13th January, 2009 S&R Communications Group
DURHAM, N.C., Jan. 13 /PRNewswire/ -- S&R Communications Group has entered a strategic partnership with Ovation Pharmaceuticals, Inc., to launch Xenazine* (tetrabenazine), a treatment for
Cambridge Laboratories Announces Approval of Tetrabenazine in Spain 8th December, 2008
DUBLIN and NEWCASTLE, England, December 8 /PRNewswire/ -- Cambridge Laboratories Limited ("Cambridge" or "the Company"), the privately-owned specialty pharmaceutical company, today
Cambridge Laboratories Announces Launch of XENAZINE(R) (Tetrabenazine) in the US 1st December, 2008
NEWCASTLE, England, December 1 /PRNewswire/ -- Cambridge Laboratories Group Limited ("Cambridge"), the privately-owned specialty pharmaceutical company, today announces that XENAZINE(R)

BioNews Results for Cambridge Laboratories:

Medical News: UK Research Community's Response To H1N1 Pandemic
BioFind:  Nov 12 2009 6:18PM Matching: cambridge laboratories
UK Research Community's Response To H1N1 Pandemic
Medical News Today:  Nov 12 2009 6:55PM Matching: cambridge laboratories
UK research funders announce support for a series of H1N1 2009 research projects
News-Medical.Net:  Nov 12 2009 1:41PM Matching: cambridge laboratories
PanGenetics Sells Antibody Rights To Abbott F
Hemscott:  Nov 12 2009 5:14PM Matching: cambridge laboratories
Build it Boldly, and Pharma Will Comeand More Wisdom from BostonEURs Biotech and Pharma Elite at Xconomy For
Xconomy:  Nov 6 2009 1:56AM Matching: cambridge laboratories
Promote your company here: BioNewsCast - Press Release Distribution

View more Cambridge Laboratories news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 382 times since April 2007, the link to the organisation's website has been followed 56 times

Recent Search Terms used to find this page: NPP1 INHIBITORS 2009 | cambridge laboratories ltd news 2009 | cambridge laboratories group dublin 4 | Latest News on Cambridge Laboratories Newcastle | cambridge labo | cambridge laboratories | pfizer global r d cambridge labs | CAMBRIDGE LABORATORIES ACQUISITION | cambridge laboratories July 2009 | cambridge laboratories 22nd july 2009 | .

Search for more companies in Dublin 4

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Cambridge Laboratories

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.